Assessment of Corona Burden Tool
Like other respiratory illnesses, COVID-19, the disease caused by the novel coronavirus, can cause lasting lung damage. The recently launched “Assessment of Corona Burden Tool” (Corona Ziektelastmeter), helps people who were infected with the virus to get more control over the complaints they may experience.
The tool consists of a questionnaire that addresses several possible complaints. It examines the physical, emotional, psychological and / or social aspects that play a role in the perceived burden of disease. The tool provides a simple visualization of outcomes, which gives users insight in the severity of their complaints. If necessary, they can be referred to a healthcare provider. Furthermore, the visualisation helps patients and healthcare providers set a personal goal and make an individual treatment plan. The tool can be used several times to see the developments over time.
This assessment of burden tool has initially been developed for people with the respiratory disease COPD (ABC tool). Studies showed that use of the ABC tool increases quality of life and quality of care in patients with COPD. Together with the Lung Foundation Netherlands, prof. Onno van Schayck and his team (RL Optimising Patient Care) adapted the tool for people who have had a corona infection, based on information from the RIVM and studies from abroad. This disease burden tool has not yet been studied within this specific patient group. Therefore is not yet known whether all complaints are included in the tool and whether the severity of the complaints is accurately displayed. It will be validated in the coming months.
Also read
-
Cells, pigments or food: looking through the eyes of a microscope
How do you make the tiniest cells visible? At the Microscopy CORE Lab. Kèvin Knoops leads this research platform for light and electron microscopy.
-
Gut bacterium may help maintain weight loss
Researchers at Maastricht University and Wageningen University & Research have made a promising discovery in the fight against obesity. A new clinical study shows that a specific gut bacterium may help limit weight regain after dieting.UM news
-
Collaborative Maastricht University team receives Open Science NL funding
A multidisciplinary team of UM researchers and support staff has been awarded a €250,000 grant from Open Science NL. Their project will highlight an often-overlooked part of academic research: the people who support it behind the scenes.
